← Back to Search

Behavioral Intervention

RELIEF for Chronic Pain (Relief Trial)

N/A
Waitlist Available
Led By Dimitris Kiosses, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Non-cancer related chronic pain, defined as pain during most days over the past 3 months by patient report
Age 50 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6, 9, and 12 weeks
Awards & highlights

Relief Trial Summary

This trial is testing whether a 9 session behavioral intervention can help relieve chronic pain and depression.

Eligible Conditions
  • Chronic Pain
  • Depression

Relief Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
, was highly prevalent, affecting more than three-quarters of participants More than three-quarters of participants reported experiencing chronic pain that wasn't cancer-related during most days over the past 3 months.
Select...
old This person is 50 years old.
Select...
A person who scores a PHQ-9 greater than or equal to 10 is classified as having major depression.

Relief Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6, 9, and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6, 9, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Clinically Significant Depressive Symptoms, as Measured by the Montgomery Asberg Depression Rating Scale (MADRS)
Change in Pain-related Disability, as Measured by the Roland-Morris Disability Questionnaire (RMDQ)
Client Satisfaction Questionnaire (CSQ)
Secondary outcome measures
Activities Monitoring
Change in Mood, as Measured by the Daily Photographic Affect Meter (PAM)

Relief Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ReliefExperimental Treatment1 Intervention
Relief relies on a neurobiological model to simplify its behavioral targets and uses mobile technology to augment its interventions. Relief was co-developed with our primary care partners with the goal to be usable by non-physician clinicians of primary care offices eligible to provide billable services.
Group II: ReferralActive Control1 Intervention
Referral for mental health based on clinical indication.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
RELIEF
2018
N/A
~80

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,052 Previous Clinical Trials
1,329,799 Total Patients Enrolled
16 Trials studying Chronic Pain
1,962 Patients Enrolled for Chronic Pain
National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,230 Total Patients Enrolled
4 Trials studying Chronic Pain
1,279 Patients Enrolled for Chronic Pain
Dimitris Kiosses, PhDPrincipal InvestigatorWeill Medical College of Cornell University
6 Previous Clinical Trials
542 Total Patients Enrolled
2 Trials studying Chronic Pain
157 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Weill Cornell Internal Medicine Associates (WCIMA)
Irving Sherwood Wright Center
What portion of applicants met pre-screening criteria?
Met criteria
~10 spots leftby Mar 2025